Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Extensior 0.5 mg is a prescription-based, once-weekly injection used for managing type 2 diabetes and long-term weight control in adults. It contains the active ingredient semaglutide and is marketed in India through a partnership between Abbott and Novo Nordisk.
| Strength | 0.5 mg |
| Mechanism of Action | GLP-1 receptor agonist |
| Storage | 2°–8°C (Refrigerator), do not freeze |
| Form | Prefilled Pen (1.5 ml) with disposable needles |